Bempedoic acid for treating primary hypercholesterolaemia or mixed dyslipidaemia: Appraisal consultation document

DRAFT guidance does not recommend use as cost-effectiveness estimates for bempedoic acid with ezetimibe are not what NICE normally considers an acceptable use of NHS resources.

National Institute for Health and Care Excellence